Patent · US Active

Blood glucose level control

US8700161B2 · kind B2 · utility

80Cited by

398References

60Claims

0Family size

Assignee

MetaCure Limited · BM

Inventors

Tami Harel · Haifa, IL
Shai Policker · Tenafly, US
Radwan Khawaled · Haifa, IL
Yuval Mika · Closter, US
Offer Glasberg · Zichron Ya'akov, IL
Aharon Grossman · Durham, US

Key dates

Filing date	Sep 4, 2003
Grant date	Apr 15, 2014
Priority date	—
Expiry date	Oct 29, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61N1/36178
WIPO fieldMedical technology
WIPO sectorInstruments

Abstract

A method of glucose level control, comprising providing at least one electrode adapted to apply an electric field to a pancreas; and applying an electric field to the pancreas using the above-mentioned at least one electrode such that blood glucose levels are significantly reduced and blood insulin levels are not significantly increased.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.